Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetaminophen versus ibuprofen for patent ductus arteriosus closure in neonates
IRCT20170910036112N2Phase 3Completed
- Sponsor
- Kashan University of Medical Sciences
- Start
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in patent ductus arteriosus (PDA) comparing Intravenous acetaminophen with Oral ibuprofen (2 arms). Primary endpoint: Closure of patent ductus arteriosus. Started Sep 2017; status: completed.
02
Drugs
acetaminophenibuprofen
03
Conditions
patent ductus arteriosus (PDA)
Beyond the preview
Go deeper on IRCT20170910036112N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170910036112N2.